Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice

被引:110
作者
Li, Q
Wichems, CH
Ma, L
Van de Kar, LD
Garcia, F
Murphy, DL
机构
[1] NIMH, Clin Sci Lab, NIH, Ctr Clin, Bethesda, MD 20892 USA
[2] Loyola Univ Chicago, Dept Pharmacol, Stritch Sch Med, Maywood, IL USA
关键词
DOI binding; in situ hybridization; 5-HT2A mRNA; 5-HT2C mRNA; G(q/11) proteins; hormones;
D O I
10.1046/j.1471-4159.2003.01607.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of the present studies was to determine the effects of reduced or absent serotonin (5-HT) transporters (5-HTTs) on 5-HT2A and 5-HT2C receptors. The density of 5-HT2C receptors was significantly increased in the amygdala and choroid plexus of 5-HTT knockout mice. On the other hand, the density of 5-HT2A receptors was significantly increased in the hypothalamus and septum, but reduced in the striatum, of 5-HTT knockout mice. However, 5-HT2A mRNA was not changed in any brain region measured. 5-HT2C mRNA was significantly reduced in the choroid plexus and lateral habenula nucleus of these mice. The function of 5-HT2A receptors was evaluated by hormonal responses to (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Oxytocin, but not adrenocorticotrophic hormone or corticosterone, responses to DOI were significantly greater in 5-HTT knockout mice. In addition, G(q) and G(11) proteins were not significantly changed in any brain region measured. The present results suggest that the constitutive alteration in the function of 5-HTTs changes the density of 5-HT2A and 5-HT2C receptors in a brain region-specific manner. These changes may not be mediated by alterations in their gene expression or in the level of G(q/11) proteins. The alterations in these receptors may be related to the altered behaviors of 5-HTT knockout mice.
引用
收藏
页码:1256 / 1265
页数:10
相关论文
共 42 条
[1]  
Bagdy G, 2001, INT J NEUROPSYCHOPH, V4, P399, DOI 10.1017/S1461145701002632
[2]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[3]   Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("ecstasy") in serotonin transporter-deficient mice [J].
Bengel, D ;
Murphy, DL ;
Andrews, AM ;
Wichems, CH ;
Feltner, D ;
Heils, A ;
Mössner, R ;
Westphal, H ;
Lesch, KP .
MOLECULAR PHARMACOLOGY, 1998, 53 (04) :649-655
[4]   Regulation of serotonin-2C receptor G-protein coupling by RNA editing [J].
Burns, CM ;
Chu, H ;
Rueter, SM ;
Hutchinson, LK ;
Canton, H ;
SandersBush, E ;
Emeson, RB .
NATURE, 1997, 387 (6630) :303-308
[5]  
Canton H, 1996, MOL PHARMACOL, V50, P799
[6]   A predicted cortical serotonergic/cholinergic/gabaergic interface as a site of pathology in schizophrenia [J].
Dean, B .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2001, 28 (1-2) :74-78
[7]   Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis in SHR and WKY rats [J].
Durand, M ;
Berton, O ;
Aguerre, S ;
Edno, L ;
Combourieu, I ;
Mormède, P ;
Chaouloff, F .
NEUROPHARMACOLOGY, 1999, 38 (06) :893-907
[8]  
Franklin K B J, 2008, MOUSE BRAIN STEREOTA
[9]   EVIDENCE THAT MCPP-INDUCED ANXIETY IN THE PLUS-MAZE IS MEDIATED BY POSTSYNAPTIC 5-HT2C RECEPTORS BUT NOT BY SYMPATHOMIMETIC EFFECTS [J].
GIBSON, EL ;
BARNFIELD, AMC ;
CURZON, G .
NEUROPHARMACOLOGY, 1994, 33 (3-4) :457-465
[10]   Paradoxical trafficking and regulation of 5HT2A receptors by agonists and antagonists [J].
Gray, JA ;
Roth, BL .
BRAIN RESEARCH BULLETIN, 2001, 56 (05) :441-451